KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Investing Activities (2016 - 2025)

Bausch Health Companies' Cash from Investing Activities history spans 17 years, with the latest figure at -$282.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 41.0% year-over-year to -$282.0 million; the TTM value through Dec 2025 reached -$595.0 million, down 31.06%, while the annual FY2025 figure was -$595.0 million, 31.06% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$282.0 million at Bausch Health Companies, down from -$83.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $588.0 million in Q3 2021 and bottomed at -$1.9 billion in Q3 2023.
  • The 5-year median for Cash from Investing Activities is -$79.5 million (2021), against an average of -$154.4 million.
  • The largest annual shift saw Cash from Investing Activities soared 940.0% in 2021 before it crashed 3464.15% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$80.0 million in 2021, then tumbled by 70.0% to -$136.0 million in 2022, then decreased by 8.82% to -$148.0 million in 2023, then plummeted by 35.14% to -$200.0 million in 2024, then crashed by 41.0% to -$282.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Cash from Investing Activities are -$282.0 million (Q4 2025), -$83.0 million (Q3 2025), and -$100.0 million (Q2 2025).